Peter Marks, MD, PhD


Turning Gene Therapy Into Reality: Peter Marks, MD, PhD

The director of the Center for Biologics Evaluation Research at the FDA provided an overview of the Keynote Address he gave at the 2023 Muscular Dystrophy Association Clinical and Scientific Conference. [WATCH TIME: 3 minutes]

Carsten G. Bönnemann, MD


Gaining a Clearer Picture of Gene Therapy in Neuromuscular Disease: Carsten G. Bönnemann, MD

The senior investigator in the Neuromuscular and Neurogenetic Disorders of Childhood Section at NINDS shared his perspective on the data coming out of neuromuscular research and the promise of genetic medicine. [WATCH TIME: 2 minutes]

Isabella Ciccone, MPH


World MS Day: Cognitive Function in Multiple Sclerosis

In recognition of World MS Day, Meghan Beier, PhD, MA, a health and rehabilitation psychologist at the Rowan Center for Behavioral Medicine, discussed the effects of multiple sclerosis (MS) on cognitive function.

Rachel Haines, MA, CCC-SLP, MSCS, CBIS


Overcoming Challenges and Early Intervention for Speech Therapy in MS: Rachel Haines, MA, CCC-SLP, MSCS, CBIS

At CMSC 2023, the neuromuscular and movement disorders speech-language pathologist at Orlando Health discussed the importance of early intervention in speech and communication therapy, as well as the challenges faced in getting patients to seek therapy at the time of diagnosis. [WATCH TIME: 5 minutes]

Debra Stultz, MD


Unmet Needs in Narcolepsy and Clinical Pearls

Neurology experts discuss the unmet needs in narcolepsy treatment and share clinical pearls from their experiences.

Saar Anis, MD


Ongoing Therapeutic Developments for Movement Disorders: Saar Anis, MD

When asked about developments, the neurologist and movement disorders specialist at Sheba Tel-HaShomer Medical Center in Israel commented on the need to identify disease-modifying therapies. [WATCH TIME: 3 minutes]

Alice Lam, MD, PhD


Increased Risk of Epilepsy in Older Adults and the Growing Population: Alice Lam, MD, PhD

The assistant professor of neurology at Massachusetts General Hospital and Harvard Medical School spoke about the high risk of epilepsy for the older population at the 2022 AES annual meeting. [WATCH TIME: 1 minute]

Larisa Reyderman, PhD


Emerging Tools for Early Detection of Alzheimer Disease

The field of Alzheimer disease has entered a new era of earlier detection, creating an opportunity to redefine treatment and the clinical care of patients.

W. Alex Dalrymple, MD


Gait Dysfunction in Parkinson Disease: The Role of the Cholinergic System

Although combination carbidopa-levodopa has become a standard for the treatment of many of the motor features of PD to this day, gait dysfunction remains a difficult symptom to treat.

Andrew Spector, MD


Patient Evaluation for Excessive Daytime Sleepiness

Excessive daytime sleepiness is a hallmark of a number of sleep disorders, and ensuring the proper diagnosis and management of those presenting with it is crucial to care.

Sudhir Sivakumaran, PhD


Identifying Impactful Biomarkers of Alzheimer Disease: Sudhir Sivakumaran, PhD; Klaus Romero, MD, MS, FCP

The duo from the Critical Path Institute detailed the thought process behind evaluating the importance of specific biomarkers and their relation to disability progression in Alzheimer disease.

Larry B. Goldstein, MD


AUPN Leadership Minute Episode 26: Creating a Formal Junior Faculty Development Plan

Episode 9 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Larry B. Goldstein, MD, of University of Kentucky Medical Center. [WATCH TIME: 8 minutes]

Gonul Ozay, MD


Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.

Albert L. Wright, Jr.


AUPN Leadership Minute Episode 10: What Your CEO Wants From You

Episode 10 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and Albert L. Wright, Jr., the president and CEO of West Virginia University Health System. [WATCH TIME: 4 minutes]

Suzan Khoromi, MD, MHS


Cluster Headache: A Clinical Overview

As the most common trigeminal autonomic cephalalgia, this unilateral and severe headache is accompanied by ipsilateral autonomic features and is often challenging to treat.

Darina Petrovsky, PhD, RN


Music-Based Application to Improve Insomnia in Patients With Dementia and Their Caregivers: Darina Petrovsky, PhD, RN

The assistant professor, Rutgers University, New Brunswick, New Jersey, offers an overview on her ongoing lab project about a music-based intervention to improve insomnia in dementia and caregivers. [WATCH TIME: 3 minutes]

Tom Crawford, MD


Unmet Needs in the Treatment of Spinal Muscular Atrophy

A panel of experts considers current unmet needs in SMA by emphasizing the need for further study of combination therapy, more comprehensive newborn screening, and more effective early diagnosis and treatment.

Mehmood Rashid, MD


AUPN Leadership Minute Episode 3: Teaching Millennial Medical Students

Episode 3 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Mehmood Rashid, MD, of University of Toledo. [WATCH TIME: 4 minutes]

Russell Lebovitz, MD, PhD


Detecting Parkinson Disease at Early Stages With Alpha-Synuclein Amplification Assay: Russell Lebovitz, MD, PhD

The CEO and cofounder of Amprion spoke about additional diagnostic uses of the αSyn seed amplification assay and its validation in the Parkinson's Progression Markers Initiative study at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]

Tina Duong, PhD, PT


Holistic Approach to Medicine and Rehabilitation in Physical Therapy: Tina Duong, PhD, PT

The director of clinical outcomes and research development in neurology at Stanford University spoke about the paradigm shift in neuromuscular therapy interventions at the 2023 MDA conference. [WATCH TIME: 5 minutes]

Garey H. Noritz, MD


Advice to Community Neurologists Treating SMA

Closing thoughts on advice to community neurologists treating spinal muscular atrophy (SMA).

Kevin Flanigan, MD


Advances in Gene Therapy for Neuromuscular Diseases: Kevin Flanigan, MD

The director of the center for gene therapy at Nationwide Children's Hospital talked about the challenges and opportunities of gene therapies for neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 4 minutes]

Aarushi Suneja, MD


Nerve Blocks for the Treatment of COVID-19 Headache: Aarushi Suneja, MD

The headache fellow at Cleveland Clinic outlined the design and reasoning for a new study assessing nerve blocks to treat COVID-19 headache.

Milena Pavlova, MD


Influence of Antiepileptic Medications on Seizure Frequency in Insomnia: Milena Pavlova, MD

At the 2022 AES annual meeting, the associate professor at Harvard Medical School and neurologist at the Brigham and Women's Hospital talked about seizure frequency and insomnia. [WATCH TIME: 2 minutes]

Richard Williamson, MD, FAANS


How Robotics Are Revolutionizing the Future of Neurosurgery: Richard Williamson, MD, FAANS

The neurosurgeon at Allegheny Health Network detailed the potential for robotics in neurosurgery over the coming years, and the vast improvements in comfortability during these procedures. [WATCH TIME: 3 minutes]

Lauren B. Krupp, MD


The Future of Pediatric Multiple Sclerosis

Tanuja Chitnis, MD and Lauren B. Krupp, MD give insight into the future of pediatric multiple sclerosis by discussing unmet needs and advice for community neurologists.

Sana Syed, MBBS, MPH


Alternative Career Paths: Clinical Care Through Clinical Research

For women, the decision to opt for an unconventional career path can be inspired by conflicting responsibilities and balancing life with work. But, as Sana Syed, MD, MPH, explains, following your passion is still an achievable dream despite these challenges.

Charlene Gamadelo, MD


Insomnia Treatment Selection: DORA

Charlene Gamaldo, MD, discusses patient criteria for selecting a dual orexin receptor agonist (DORA) for insomnia treatment.

Carolina Ferreira Atuesta, MD, MSc


Post-Stroke Seizure Predictive Models, SeLECT Model: Carolina Ferreira Atuesta, MD, MSc

The scientific researcher and clinical manager, Icahn School of Medicine at Mount Sinai, spoke about the clinical models used to predict seizures in poststroke patients. [WATCH TIME: 4 minutes]

© 2023 MJH Life Sciences

All rights reserved.